GlassScriptPhysician profile
Qi Li Ye
NPI 1447548961
$1,587.94
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $527 · 2021: $795 · 2022: $17.08.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $397.78 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $213.59 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $193.86 | 2020-2021 | |
| Grt US Holding, INC. | $123.63 | 2020-2021 | |
| Medtronic USA, INC. | $104.17 | 2019 | |
| Amgen INC. | $68.10 | 2021 | |
| Abbvie INC. | $58.59 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $52.75 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $47.19 | 2020-2021 | |
| Abbott Laboratories | $45.84 | 2019-2021 | |
| Redhill Biopharma INC. | $38.98 | 2021 | |
| Novartis Pharmaceuticals Corporation | $35.40 | 2020-2021 | |
| Electronic Waveform Lab, INC. | $31.97 | 2021 | |
| Horizon Therapeutics Plc | $31.30 | 2019-2020 | |
| Lilly USA, LLC | $28.15 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $27.03 | 2021 | |
| Almatica Pharma LLC | $25.08 | 2021 | |
| Arbor Pharmaceuticals, INC. | $25.00 | 2020 | |
| Biodelivery Sciences International, INC. | $24.60 | 2021 | |
| Ermi LLC | $14.93 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qi Ye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.